π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Primary Objective: \- To determine the maximum tolerated dose(s) (MTD) and...
Status
Completed
Location
Investigational Site Number 840001
Start Date
2011-05
Trial ID
NCT01357330
Treatments Being Tested
Phase 1 of this study will evaluate the maximum tolerated dose (MTD) of XL1...
Status
Completed
Location
Investigational Site Number 1537
Start Date
2010-02
Trial ID
NCT01042925
Treatments Being Tested
Primary Objective: The purpose of this study was to determine the long ter...
Status
Completed
Location
Investigational Site Number 840010
Start Date
2012-07-20
Trial ID
NCT01587040
Primary Objective: \- To confirm safety and tolerability of global recomme...
Status
Completed
Location
Investigational Site Number 392002
Start Date
2011-08
Trial ID
NCT01392924
Treatments Being Tested
Phase 1 of this study will evaluate the maximum tolerated dose (MTD) of XL1...
Status
Completed
Location
Investigational Site Number 1537
Start Date
2010-06
Trial ID
NCT01082068
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of XL1...
Status
Completed
Location
Investigational Site Number
Start Date
2008-09
Trial ID
NCT00756847
Treatments Being Tested
Primary Objective: * To determine the maximum tolerated dose (MTD) and rec...
Status
Completed
Location
Investigational Site Number 840001
Start Date
2011-11
Trial ID
NCT01436565
Treatments Being Tested
Primary Objective: \- To assess the safety, tolerability and plasma pharma...
Status
Completed
Location
Investigational Site Number 056001
Start Date
2013-10
Trial ID
NCT01943838
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and hig...
Status
Withdrawn
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-06
Trial ID
NCT00704392
There has not been any systemic therapy approved in the United States or in...
Status
Completed
Location
Investigational Site Number 1526
Start Date
2010-01
Trial ID
NCT01013324
Treatments Being Tested